InvestorsHub Logo

AgeOfReason

04/29/21 9:36 AM

#5992 RE: AgeOfReason #5990

Yesterday another news source also reported on VXRT. It said:

"Vaxart COVID-19 Tablet Potentially Effective Against New Strains; Shares Soar

2:57 PM ET, 04/27/2021 - MT Newswires
02:57 PM EDT, 04/27/2021 (MT Newswires) -- Vaxart (VXRT) shares rose 38% after saying it will present new mucosal antibody data and review the recent phase I clinical results that suggest its VXA-CoV2-1 tablet is potentially protective against new and emerging COVID-19 strains.

At a May 3 webinar, the company's management will provide new data comparing the T-cell responses generated from its vaccine with those of other vaccines, according to a Tuesday news release.

Price: 8.39, Change: +2.33, Percent Change: +38.37"